{"city":"Paris","name":"Sanofi","slug":"sanofi","facts":[{"date":"2025-02-03","type":"ownership_change","value":"EUR 3000000000","source":"loreal.com"},{"date":"2025-02-03","type":"ownership_change","value":"Sanofi agreed to repurchase approximately 29.6 million shares from L’Oréal; after cancellation, L’Oréal retained 7.2% of Sanofi’s share capital and 13.1% of voting rights.","source":"loreal.com"},{"date":"2025-01-01","type":"revenue","value":"EUR 43626000000","source":"sanofi.com"},{"date":"2024-12-31","type":"headcount","value":"82878","source":"sanofi.com"},{"date":"2024-05-21","type":"partnership","value":"Sanofi, Formation Bio and OpenAI agreed to build AI-powered software and develop custom AI models for drug development using Sanofi proprietary data.","source":"sanofi.com"},{"date":"2023-06-13","type":"deployment","value":"Sanofi rolled out plai, an AI-powered application developed with Aily Labs, at scale across the company to provide real-time data interactions and decision support.","source":"sanofi.com"}],"peers":[],"stage":"public","state":"Île-de-France","aliases":[],"country":"France","domains":[{"why":"Sanofi develops AI for drug research and operations, including CodonBERT for mRNA design, generative chemistry and clinical-trial modeling.","list":null,"rank":null,"tier":"watchlist","layer":null,"total":40,"domain":"AI Core","scores":{"gate_ne":["firepower"],"leverage":6,"position":4,"progress":4,"firepower":1,"commercial":10,"deployment":1,"production":10,"technology":3},"edition":null,"segment":null}],"founded":null,"signals":[{"date":"2026-06-18","header":"Sanofi is deploying AI agents across research, manufacturing, commercial operations, procurement and IT.","outlet":"NVIDIA blogs"},{"date":"2026-04-29","header":"Najat Khan became CEO of Recursion Pharmaceuticals on January 1, 2026, succeeding founder Chris Gibson.","outlet":"The AI Insider"},{"date":"2026-03-31","header":"Sanofi will provide scientific and digital support for AI-assisted treatment discovery at Station F.","outlet":"Maddyness"},{"date":"2025-11-07","header":"Anthropic serves L’Oréal, Sanofi, Doctolib, Pigment, Qonto, and Dust in France.","outlet":"Maddyness"},{"date":"2025-10-06","header":"Sanofi is using OpenAI tools to accelerate the development of life-saving medical treatments.","outlet":"OpenAI"},{"date":"2025-09-19","header":"Juisci has secured more than 30 major clients across healthcare and life sciences.","outlet":"EU-Startups"}],"website":"https://www.sanofi.com","category":"AI · Models & applications","categories":[{"name":"Specialized models","domain":"AI Core","parent":"AI · Models & applications"},{"name":"Unspecified","domain":"Unspecified","parent":null}],"last_round":null,"updated_at":"2026-10-04T14:14:56.208305+00:00","facts_total":17,"positioning":"","sub_category":"Specialized models","signals_total":9,"url":"https://www.frontiertechintelligence.com/companies/sanofi","title":"Sanofi · ai core, Paris, Île-de-France, France · scores, facts and signals · Frontier Tech Intelligence","description":"Sanofi develops AI for drug research and operations, including CodonBERT for mRNA design, generative chemistry and clinical-trial modeling. AI Core watchlist (score 40) 9 signals and 17 facts with sources.","publisher":"Frontier Tech Intelligence (Future Frontiers, a trade name of Essential Cognition Inc.)","note":"Assessment by Frontier Tech Intelligence; facts and signals carry their sources."}